
Cost Effectiveness of Emollients in the Prevention of Relapses in Atopic Dermatitis
Author(s) -
E. Cabout,
S. Eymere,
R Launois,
Flavia M. N. P. Aslanian,
C. Taïeb,
Sophie Seité
Publication year - 2020
Publication title -
clinical, cosmetic and investigational dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 35
ISSN - 1178-7015
DOI - 10.2147/ccid.s279233
Subject(s) - medicine , atopic dermatitis , quality of life (healthcare) , randomized controlled trial , dermatology , pediatrics , nursing
Atopic dermatitis (AD) is chronic inflammatory skin condition, characterized by its remission-relapse cycles. This predominantly pediatric disease is becoming more and more prevalent. Emollients are part of the therapeutic management and particularly a way to increase time between relapses. The follow-up of AD and relapses have a great impact on patient's quality of life, expenditures and society costs. The aim of this study is to assess the cost-effectiveness of different emollients prescribed to AD patients.